Registered entities
Agenebio, Inc.
Reg. No. 4556611United States
Innovation
19 patent families (9 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady.
Therapeutic to treat amnestic mild cognitive impairment (aMCI) due to Alzheimer’s disease.
19 patent families (9 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady.